LEADER 02053nam  22003975u 450 
001 9910156327403321
005 20211006144823.0
010   $a3-318-03383-9
035   $a(CKB)3780000000101275
035   $a(OCoLC)1046113272
035   $a(SZ-BaSKA)223018
035   $a(EXLCZ)993780000000101275
100   $a20211006d1996      uy             0
101 0 $aeng
135   $aurunu|||||
200 10$aClinical Hypertension in Nephrology : $eInternational Meeting, Lido degli Aranci, Calabria, September 1995 / $f editor, C. Zoccali
210   $aBasel : $cS. Karger, $d1996
215   $a1 online resource (X + 216 pages) : $c  35 figures, 32 tables
225 0 $aContributions to Nephrology, $x1662-2782 ; $vVol.119
311   $a3-8055-6301-9 
330   $aThis volume takes a fresh look at a range of hypertension topics that are of primary interest to the clinical nephrologist. The book includes balanced reviews on the clinical physiology of endothelin and nitric oxide and the role of these substances in primary and secondary hypertension. Some still unsolved problems in the diagnosis and treatment of renovascular hypertension and renal ischemia are reexamined in light of the latest results from ongoing studies. The problem of ?renal risk? in essential hypertension is addressed mainly in terms of early prediction and the importance of microalbuminuria and glomerular hyperfiltration is thoroughly discussed. Finally, the increased cardiovascular risk and hemodynamic instability in patients undergoing dialysis are reevaluated on the basis of the most recent studies.
606   $aNephrology
606   $aInternal Medicine
606   $aCardiovascular System
615 14$aNephrology
615 14$aInternal Medicine
615 24$aCardiovascular System
676   $a616.6/1
700   $aZoccali$b C
701   $aZoccali$b Carmine$f1947-$01209683
801  0$bUKSKG
801  1$bUKSKG
906   $aBOOK
912   $a9910156327403321
996   $aClinical Hypertension in Nephrology$92860985
997   $aUNINA